glp 1 agonists anesthesia How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like GLP-1 drugs and aspiration risk
Description
A possible explanation for the similar effects on weight of both GIP agonism and antagonism is the potential desensitisation of GIP receptors by GIP agonists exposure [57]

Benefits of GLP-1s Beyond Weight Loss: Neurodegenerative and Joint Disorders Theres even interesting data emerging around neurodegenerative conditions such as Parkinsons and Alzheimers disease
Who Should Avoid GLP-1 Medications Genetic and Cancer Concerns If you or your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), GLP-1 medications come with an increased risk of thyroid C-cell tumors and should be avoided

M., Delporte, M

doi: 10.1111/j.1464-5491.2008.02484.x

These results suggest PI3K/Akt/mTOR signaling mediated the protection of GLP-1 on apoptosis in neurons (193)
